Previous 10 |
You can read full article here. For further details see: Wall Street Breakfast: The Week Ahead (Podcast)
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Investors will get some hard reads on the U.S. consumer next week, with earnings reports due out from Walmart, (NYSE:WMT...
Caribou Biosciences Inc. (NASDAQ:CRBU) traded at a new 52-week high today of $28.26. So far today approximately 135,000 shares have been exchanged, as compared to an average 30-day volume of 618,000 shares. Caribou Biosciences Inc. (NASDAQ:CRBU) is currently priced 12.2% above its averag...
Shares of Caribou Biosciences Inc. (NASDAQ:CRBU) traded today at $25.80, eclipsing its 52-week high. This new high was reached on below average trading volume as 135,000 shares traded hands, while the average 30-day volume is approximately 537,000 shares. Caribou Biosciences Inc is a cli...
Gainers: SCWorx (NASDAQ:WORX) +28%, Aurinia Pharmaceuticals (NASDAQ:AUPH) +21%, BeyondSpring (NASDAQ:BYSI) +13%, Intersect ENT (NASDAQ:XENT) +12%, Caribou Biosciences (NASDAQ:CRBU) +11%. Losers: Dicerna Pharmaceuticals (NASDAQ:DRNA) -35%, iCAD (NAS...
Shares of Caribou Biosciences Inc. (NASDAQ:CRBU) traded at a new 52-week high today of $21.03. This new high was reached on below average trading volume as 135,000 shares traded hands, while the average 30-day volume is approximately 470,000 shares. Caribou Biosciences Inc. (NASDAQ:CRBU)...
Last week’s 19 IPO week had a lot of life sciences and software. This week, US IPO activity continues at a record with 25 scheduled IPOs, marking the fifth week in 2021 with at least 17 US IPOs, the most since 2000. With the August lull just around the corner, five SPACs raised $895....
News, Short Squeeze, Breakout and More Instantly...
Caribou Biosciences Inc. Company Name:
CRBU Stock Symbol:
NASDAQ Market:
Caribou Biosciences Inc. Website:
-- Dr. Laufer is an immunologist advancing the scientific understanding and treatment of autoimmune diseases -- BERKELEY, Calif., July 09, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today a...
2024-06-04 08:30:04 ET H.C. Wainwright analyst issues BUY recommendation for CRBU on June 4, 2024 06:46AM ET. The previous analyst recommendation was Buy. CRBU was trading at $2.145 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...
A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 22.3% to $0.12231 on volume of 147,748,197 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 11.8% to $0.6524 on volume of 95,235,738 shares AMC Entertainment Holdings Inc. Class A (AM...